Got $5,000? 3 Stocks to Hold for the Next 20 Years

Long-term investors can consider buying shares of Dollarama and Curaleaf to generate market-beating gains in the next two decades.

| More on:

It’s imperative for stock market investors to have a long-term view of equities, given the S&P 500 has returned 10% annually in the last five decades. So, you need to identify companies that have the potential to grow your wealth over time. These companies should ideally enjoy a wide economic moat and be part of rapidly expanding addressable markets to consistently outpace the broader market.

Here I have identified three such stocks Canadians can buy and hold for the next 20 years.

Brookfield Renewable Partners

One of the largest companies in the renewable energy space, Brookfield Renewable Partners (TSX:BEP.UN)(NYSE:BEP) operates 21 gigawatts (GWs) of clean energy assets. These assets consist of wind, hydro, and solar energy. It has a development pipeline of 69 GWs of projects, allowing BEP to triple its existing portfolio in the process.

To achieve its portfolio expansion goals, Brookfield Renewable is likely to deploy over US$1 billion in capital expenditures in the next five years.

The shift towards clean energy solutions globally is inevitable, and Brookfield Renewable is well positioned to take advantage of this secular tailwind.

Brookfield Renewable also offers investors a tasty dividend yield of 3.4%, and these payouts have increased at an annual rate of 6% since 2013. While the stock is trading 16% below all-time highs, Brookfield Renewable has returned close to 480% to investors in dividend-adjusted gains since August 2012.

Curaleaf

Investors bullish on the cannabis sector in the U.S. can consider buying shares of Curaleaf (CNSX:CURA), one of the largest marijuana producers in the world. Valued at a market cap of $5.9 billion, Curaleaf is also trading 77% below all-time highs.

The cannabis heavyweight increased sales from US$77 million in 2018 to US$1.21 billion in 2021, driven by the recent wave of legalization south of the border. In the second quarter (Q2), Curaleaf increased sales by 8% year over year to US$338 million compared to the 20% growth experienced in the March quarter.

Its adjusted EBITDA (earnings before interest, tax, depreciation, and amortization) rose 18% to US$86 million, allowing Curaleaf to generate US$12 million in operating cash flow in Q2.

In the first six months of 2022, Curaleaf opened 28 new stores, taking its total count to 145 stores in the United States. Curaleaf’s acquisition of Bloom provides it access to Arizona while it began recreational sales in New Jersey earlier this year. Both states are billion-dollar markets and will be key drivers of revenue growth for Curaleaf in the next decade.

Dollarama

One of the top-performing TSX stocks, shares of Dollarama (TSX:DOL) have gained 758% since August 2012, easily crushing the broader markets. Shares of the discount retailer have surged 40% year to date, as consumer spending shifts towards consumer staple goods amid high inflation rates.

With 1,421 outlets, Dollarama is Canada’s largest discount retailer and benefits from its wide portfolio of low-cost products. Rising commodity prices and higher interest rates have reduced discretionary spending levels in Canada, spiking demand for Dollarama’s products.

Due to its market-thumping gains, Dollarama stock is valued at 30.8 times forward earnings, which is quite steep. But the company is also forecast to increase earnings at an annual rate of 16% in the next five years.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Aditya Raghunath has positions in Brookfield Renewable Partners. The Motley Fool has no position in any of the stocks mentioned.

More on Cannabis Stocks

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Could the Cannabis Bubble Re-Inflate?

Let's dive into the question of whether the Canadian cannabis bubble can re-inflate from here.

Read more »

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Should You Buy Canopy Growth Stock or Green Thumb Stock Today?

Let's dive into two cannabis giants, and which one may be the better pick for long-term investors.

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Could Aurora Cannabis Stock Finally Recover by Year-End?

Down 99% from all-time highs, Aurora Cannabis stock is focused on improving profit margins and expanding sales of its medical…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Are Pot Stocks About to Surge Again? 

With pot stocks making big moves of late, many investors are now asking whether the cannabis sector is worth investing…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Can Pot Stocks Aurora Cannabis and Canopy Growth Bounce Back in Q4?

Down over 99% from all-time highs, Canadian pot stocks such as Aurora Cannabis and Canopy Growth remain high-risk bets.

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Can Canopy Growth Stock Finally Recover in 2024?

Down 98% from all-time highs, Canopy Growth remains a high-risk investment in 2024 given its weak fundamentals.

Read more »

Tech Stocks

3 No-Brainer Stocks to Buy With $20 Right Now

These three stocks are easy buys for those who don't have all that much to spend, and want long-term growth…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Slow Burn: Is Aurora Cannabis Finally a Good Buy in June?

One of the benefits of choosing from some of the most beaten-down market segments like cannabis is that even a…

Read more »